CD4 antagonists (Retrovirox)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameCD4 antagonists (Retrovirox)
Drug Alias NameCD4 antagonists/HIV entry inhibitors (Retrovirox)HIV entry inhibitors (RetroVirox)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionT-cell surface antigen CD4 inhibitors
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRetroVirox Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRetroVirox Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A